Member Info for TrickyEFC

Given that dds can reduce dosage and that Awakn have previous history in regards to UK Gov funding.

Wonder if they can get some more free money

Published: 19 December 2022

A new trial will investigate whether ketamine-assisted therapy could help alcoholics stay off alcohol for longer.

The £2.4 million trial is led by the University of Exeter and will be delivered at seven NHS sites across the UK.

It is being funded by a Medical Research Council (MRC) and NIHR partnership, with more funding from biotech company Awakn Life Sciences.

Awakn CEO Anthony Tennyson added “For this phase III to have the support and funding from the NIHR and for it to be delivered in the NHS is a great endorsement of this treatment’s potential and a sign of how badly a new more effective treatment is needed to help the millions of people suffering from Alcohol addiction in the UK. We are very proud to be part of this important piece of work.

More information about the study is available on the NIHR Funding & Awards Website.

Maybe gdr plan on selling the test too share holders.

They are putting investors through the ringer

-24 16:25:28 0.194 4,350,561 Unknown* 8,440 O

28-Aug-24 16:24:00 0.19315 4,227,133 Unknown* 8,165

2 printed but again they look very much like buys

Hi Dr just curious that they dropped it but seemed to be asking 21.5p (pretty much 20% on top of displayed ask)

Looks like 23 mill bought and 10 mill sold.

Only 2 orders so far today and both buys plus that like 5mill again 2p over the ask at the time.

Very curious as into what the heck is going on here.

As someone said surely something to be revealed shortly or tomorrow in regards to orders.

Curious has anybody done a quote today and if so is the ask still at 21.5p for and slightly decent size amounts?

And another

13:52:07 0.215 5,000,000 Unknown* 10.75k

Given that last one was 10 mins or so ago at 21.5p.

Very strange Dr, given that we had two 5 million buys

This section, is just splendid

New provisional patent filed: On 27 August 2024, Awakn filed a provisional patent application with the US Patent and Trademark Office, covering a new class of aminoindane chemical entities and their derivatives. This provisional patent has been incorporated into the scope of the commercial collaboration agreement between the Company and Awakn. This filing strengthens the intellectual property portfolio underpinning the Graft Polymer-Awakn collaboration, further reinforcing the Company's competitive edge in the biopharmaceutical market.

That's the type of updates I like to see.

💪

About 14 x 2 mill last hour on Friday.

What foresight like they knew.

How to take the shine off the first RNS today.

Second RNs 🫣

No more sells at over 0.20p.

Come on you barstewards

Eureka award for you.

How have you delt with that melt for so long.

Filter it.

5mill this morning sold I bet

Nearly 10%

23-Aug-24 13:23:41 0.20 10,000,000 Unknown* 20.00k

That's why it went up on sells. Decent 10mil buy

Link

https://www.webmd.com/stroke/news/20240524/strokes-are-increasing-people-under-65

Laboratory testing is overstretched. Wonder why is it climate change 😉

May 24, 2024 – Strokes – a medical emergency typically linked to older adults – are increasing among younger people.

A study by the CDC released Thursday said self-reported incidents of stroke increased 14.6% among people ages 18 to 44 and about 15.7% among people ages 45 to 64 from 2011-2013 to 2020-2022.

We just gone up on back of some sells?

5mill buy helped nudge it up.

A good morning all. Wonder if 🐴🐴 may fly today.

It's windy enough